| Management target | Revenue 12.5% FY27 |
|---|
| Revenue growth | 11.3% YoY growth in Q1FY27. |
|---|---|
| Margins | EBITDA margins targeted at 18-20% for FY27/28. |
| Demand visibility | Strong domestic API demand; export recovery expected over the year. |
| Management confidence | High; projecting stable growth and margin expansion through product mix. |
Growth
Revenue increased 11.3% YoY; Gross margin expanded 210 bps to 48.3%; EBITDA grew to INR 29.6 Cr.
Outlook
Guided 10-15% growth for FY27; INR 40-50 Cr annual capex; new peptide and oncology plants commissioned by 2027-2028.
Risks
Geopolitical conditions affecting export normalization; dependence on stable oil prices for API pricing; high inventory levels.
Investor Presentation filed with BSE, NSE: BAJAJHCARE. Summary written with AI assistance from the document.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹344.15
- Market cap
- ₹1,159 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 65.7×Sector 50.4×
- Promoter holding
- 58.59%+0.30% QoQ
- FII holding
- 2.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Annual General Meeting
Bajaj Healthcare Limited concluded its 33rd Annual General Meeting on September 21, 2026. The shareholders transacted ordinary and special business, including a final dividend declaration.
Bajaj Healthcare Dividend
Bajaj Healthcare Limited has fixed September 14, 2026, as the record date for a 30% final dividend. The dividend of ₹1.50 per share awaits shareholder approval.
Bajaj Healthcare Earnings Call Transcript: Key Takeaways
Bajaj Healthcare is pivoting from high-volume commodities to high-margin specialized APIs and formulations, targeting a ₹1000 Cr topline via new oncology and peptide capacities.
- Call
- Guides 15% growth
Bajaj Healthcare Q1 FY27 Results: Net Profit ₹13.7 Cr, Up 16.1% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹165.6 Cr (+11.3% YoY) and net profit of ₹13.7 Cr (+16.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹13.7 Cr · +16.1% YoY
Bajaj Healthcare Q4 FY26 Results: Net Loss of ₹22.9 Cr
Bajaj Healthcare Ltd reported revenue from operations of ₹153.1 Cr (-0.9% YoY) and a net loss of ₹22.9 Cr for Q4 FY26.
- Key figure
- Net loss ₹22.9 Cr